Australian (ASX) Growth Pharmaceuticals & Biotech Stocks

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MYX Mayne Pharma Group	AU$4.49	0%	-16.1%	AU$364.8m	AU$6.10	PB0.8x	E111.4%	n/a
BOT Botanix Pharmaceuticals	AU$0.46	-3.2%	160.0%	AU$830.7m	n/a	PS401.4x	E99.4%	n/a
TRJ Trajan Group Holdings	AU$0.94	-0.5%	-17.8%	AU$144.0m	AU$1.45	PB1.4x	E98.8%	n/a
GSS Genetic Signatures	AU$0.62	-3.1%	24.0%	AU$140.8m	AU$1.10	PS10.2x	E98.6%	n/a
MVP Medical Developments International	AU$0.41	-3.5%	-55.4%	AU$46.8m	AU$2.94	PS1.4x	E93.1%	0%
ACR Acrux	AU$0.032	3.2%	-52.9%	AU$9.3m	n/a	PS1.8x	E91.8%	0%
BDX BCAL Diagnostics	AU$0.093	-1.1%	-6.1%	AU$33.4m	n/a	PS10.8x	E90.6%	n/a
CYP Cynata Therapeutics	AU$0.21	2.4%	48.3%	AU$48.4m	n/a	PS20.9x	E72.9%	n/a
OPT Opthea	AU$0.97	18.9%	99.0%	AU$1.2b	AU$1.20	PS2894.2x	E60.7%	n/a
ARX Aroa Biosurgery	AU$0.78	6.1%	6.8%	AU$269.0m	n/a	PS3.9x	E59.7%	n/a
MSB Mesoblast	AU$2.87	6.7%	983.0%	AU$3.6b	AU$2.69	PS387.9x	E55.0%	n/a
ALA Arovella Therapeutics	AU$0.20	5.3%	53.8%	AU$211.9m	n/a	PS108.5x	E47.2%	n/a
VFY Vitrafy Life Sciences	AU$1.74	3.9%	n/a	AU$110.8m	AU$2.43	PS2980.7x	E45.7%	n/a
RAD Radiopharm Theranostics	AU$0.027	-3.6%	-63.0%	AU$58.7m	n/a	PS30x	E44.1%	n/a
CU6 Clarity Pharmaceuticals	AU$4.10	4.1%	78.3%	AU$1.3b	AU$8.67	PS114.3x	E37.4%	n/a
PYC PYC Therapeutics	AU$1.07	-8.2%	26.8%	AU$496.9m	AU$8.75	PS22.5x	E36.8%	n/a
TLX Telix Pharmaceuticals	AU$27.53	3.5%	143.6%	AU$9.2b	AU$24.77	PE187.4x	E33.1%	n/a
PIQ Proteomics International Laboratories	AU$0.67	0.8%	-27.2%	AU$87.8m	n/a	PS26.8x	E28.8%	n/a
CUV Clinuvel Pharmaceuticals	AU$11.84	-0.3%	-24.3%	AU$591.4m	AU$28.23	PE16.6x	E26.2%	0.4%
SNT Syntara	AU$0.071	-2.7%	317.6%	AU$112.1m	n/a	PS19.5x	E25.3%	n/a
PER Percheron Therapeutics	AU$0.009	0%	-84.5%	AU$9.8m	n/a	PS3.3x	E24.7%	n/a
IMC Immuron	AU$0.085	-7.6%	11.8%	AU$19.5m	n/a	PS4x	E22.4%	n/a
RCE Recce Pharmaceuticals	AU$0.47	0%	-11.3%	AU$109.0m	AU$2.46	PS21.7x	E18.3%	n/a
EZZ EZZ Life Science Holdings	AU$2.27	-5.0%	263.2%	AU$104.8m	AU$5.45	PE15x	E17.9%	1.3%